RxDoctor Payments Data

Kelly O'Dell, MD

Family Medicine · Oakwood, GANPI 1700226131

Payments from drug & device makers

$6,832in general payments, 2019–2025

Across 431 payments — averaging $15.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$826
  • AbbVie$577
  • AstraZeneca$538
  • Bayer$419
  • Lilly USA, LLC$418
  • Amarin Pharma, Inc.$323
  • plus $4K from 44 others

What the payments were for

  • Food & beverage$6,817100%
  • Education$150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,832 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$183,625
Medicare patients
474
Services billed
6,261

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide179$235,442
TrulicityDulaglutide117$147,574
EliquisApixaban108$132,989
FarxigaDapagliflozin Propanediol95$109,118
Trelegy ElliptaFluticasone/Umeclidin/Vilanter102$77,069
ProliaDenosumab36$61,954
OzempicSemaglutide51$60,724
JardianceEmpagliflozin54$55,880
XareltoRivaroxaban26$39,630
EntrestoSacubitril/Valsartan25$32,712
JanuviaSitagliptin Phosphate27$30,481
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog44$27,997
CreonLipase/Protease/Amylase15$27,191
LinzessLinaclotide27$26,163
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog34$20,598

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Humalog$418$389,169317 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$538$133,046131 claims
PfizerEliquis$316$132,989108 claims
GSKTrelegy Ellipta, Breo Ellipta$71$92,741132 claims
Boehringer IngelheimJardiance, Tradjenta$258$74,96267 claims
Novo NordiskOzempic, Rybelsus$826$72,90362 claims
AmgenProlia$299$61,95436 claims
AbbVieCreon, Linzess, Synthroid$577$57,08790 claims
Johnson & JohnsonXarelto$130$39,63026 claims
MerckJanuvia, Belsomra$236$39,13147 claims
NovartisEntresto$174$32,71225 claims
Astellas Pharma US IncMyrbetriq$172$11,07615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Oakwood

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →